• OPEN AN ACCOUNT
Indian Indices
Sensex
73,852.90 -876.37
( -1.17%)
Global Indices
Nasdaq
51,986.54 -36.87
(-0.07%)
Dow Jones
7,712.39 31.95
(0.42%)
Hang Seng
63,869.15 -1,047.55
(-1.61%)
Nikkei 225
10,765.28 -116.62
(-1.07%)
Forex
USD-INR
94.77 -0.08
(-0.08%)
EUR-INR
106.47 0.12
(0.11%)
GBP-INR
126.26 0.54
(0.43%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Tata Consultancy Services Ltd
Industry :  Computers - Software - Large
BSE Code
ISIN Demat
Book Value()
532540
INE467B01029
267.0411046
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TCS
16.05
890411.34
EPS(TTM)
Face Value()
Div & Yield %
153.31
1
4.47
 

Concord Biotech's Unit II formulations unit successfully clears PPB and NDA inspection
Jun 25,2026
Concord Biotech announced the successful completion of inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at Unit-II formulation facility. The inspection took place from 18 June 2026 to 24 June 2026, and was concluded successfully.